04/08/2024
4:32 PM | Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
4:22 PM | Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
7:01 PM | Aldeyra Therapeutics (Issuer)
Brady Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:04 PM | Aldeyra Therapeutics (Issuer)
Machatha Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:07 PM | Aldeyra Therapeutics (Issuer)
Greenberg Bruce (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
8:11 PM | Aldeyra Therapeutics (Subject)
Greenberg Bruce (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/11/2024
7:43 PM | Aldeyra Therapeutics (Subject)
Machatha Stephen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
6:12 PM | Aldeyra Therapeutics (Subject)
Brady Todd C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/07/2024
3:48 PM | Aldeyra Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/07/2024
3:40 PM | Aldeyra Therapeutics (Filer)
| Form S-8 POS | |
01/04/2024
6:00 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2023
6:05 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/28/2023
6:16 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
3:43 PM | Aldeyra Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/01/2023
6:09 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
5:07 PM | Aldeyra Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
10/18/2023
4:15 PM | Aldeyra Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
7:00 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
2:22 PM | Aldeyra Therapeutics (Subject)
Knoll Capital Management, LLC (Filed by)
| Form SC 13G | |
09/11/2023
4:42 PM | Aldeyra Therapeutics (Issuer)
Brady Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2023
3:31 PM | Aldeyra Therapeutics (Issuer)
Phillips Gary M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/24/2023
3:13 PM | Aldeyra Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:42 PM | Aldeyra Therapeutics (Issuer)
Miller-Rich Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:43 PM | Aldeyra Therapeutics (Issuer)
Phillips Gary M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:46 PM | Aldeyra Therapeutics (Issuer)
JOYCE MARTIN JOSEPH (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:30 PM | Aldeyra Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:32 PM | Aldeyra Therapeutics (Issuer)
DOUGLAS RICHARD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:34 PM | Aldeyra Therapeutics (Issuer)
Bronstein Ben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
3:07 PM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/29/2023
3:23 PM | Aldeyra Therapeutics (Issuer)
Bronstein Ben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2023
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:25 PM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
6:01 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
6:05 AM | Aldeyra Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
